Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A prospective, randomized, probe trial to evaluate whether, at comparable blood pressure control, combined therapy with the ACEI (angiotensin converting enzyme inhibitors) benazepril and the ARB (angiotensin II receptor blockers) valsartan, reduces the incidence of microalbuminuria more effectively than BEN (benazepril) or VAL (valsartan) alone in hypertensive patients with type 2 diabetes and high-normal albuminuria

Next Previous
X
Search
Trial Profile

A prospective, randomized, probe trial to evaluate whether, at comparable blood pressure control, combined therapy with the ACEI (angiotensin converting enzyme inhibitors) benazepril and the ARB (angiotensin II receptor blockers) valsartan, reduces the incidence of microalbuminuria more effectively than BEN (benazepril) or VAL (valsartan) alone in hypertensive patients with type 2 diabetes and high-normal albuminuria

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Nov 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Benazepril (Primary) ; Valsartan (Primary)
  • Indications Diabetic nephropathies; Hypertension; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms VARIETY

    • Most Recent Events

    • 24 May 2012 Planned end date changed from 1 Dec 2012 to 1 Dec 2015 as reported by ClinicalTrials.gov.
    • 16 Aug 2007 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top